10 February 2016 - ALK Abello announced today that its partner for North America, MSD has submitted a Biologics License Application to the U.S. FDA for its house dust mite sub-lingual allergy immunotherapy tablet.

For more details, go to: http://www.alk-abello.com/Pages/CorpFrontPage.aspx